SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year debt growth rate
Percentile
P45
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -3.82% |
| Q3 2025 | -3.60% |
| Q2 2025 | -5.37% |
| Q1 2025 | 45.28% |
| Q4 2024 | 3.29% |
| Q3 2024 | -15.39% |
| Q2 2024 | -1.99% |
| Q1 2024 | -7.72% |
| Q4 2023 | 26.97% |
| Q3 2023 | -16.58% |
| Q2 2023 | 2.13% |
| Q1 2023 | -7.89% |
| Q4 2022 | -17.17% |
| Q3 2022 | -3.28% |
| Q2 2022 | -4.06% |
| Q1 2022 | -9.42% |
| Q4 2021 | 24.84% |
| Q3 2021 | -1.37% |
| Q2 2021 | 0.00% |
| Q1 2021 | -100.00% |
| Q4 2020 | 0.00% |